The Airway Microbiome-IL-17 Axis: a Critical Regulator of Chronic Inflammatory Disease
Open Access
- 11 March 2022
- journal article
- research article
- Published by Springer Nature in Clinical Reviews in Allergy & Immunology
- Vol. 64 (2) , 161-178
Abstract
The respiratory tract is home to a diverse microbial community whose influence on local and systemic immune responses is only beginning to be appreciated. Increasing reports have linked changes in this microbiome to a range of pulmonary and extrapulmonary disorders, including asthma, chronic obstructive pulmonary disease and rheumatoid arthritis. Central to many of these findings is the role of IL-17-type immunity as an important driver of inflammation. Despite the crucial role played by IL-17-mediated immune responses in protection against infection, overt Th17 cell responses have been implicated in the pathogenesis of several chronic inflammatory diseases. However, our knowledge of the influence of bacteria that commonly colonise the respiratory tract on IL-17-driven inflammatory responses remains sparse. In this article, we review the current knowledge on the role of specific members of the airway microbiota in the modulation of IL-17-type immunity and discuss how this line of research may support the testing of susceptible individuals and targeting of inflammation at its earliest stages in the hope of preventing the development of chronic disease.Keywords
Funding Information
- Science Foundation Ireland (15/SIRG/3426)
- University College Dublin
This publication has 220 references indexed in Scilit:
- Commensal bacteria–derived signals regulate basophil hematopoiesis and allergic inflammationNature Medicine, 2012
- Fate mapping of IL-17-producing T cells in inflammatory responsesNature Immunology, 2011
- Proinflammatory T helper type 17 cells are effective B-cell helpersProceedings of the National Academy of Sciences, 2010
- Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosisThe ISME Journal, 2010
- Gut-Residing Segmented Filamentous Bacteria Drive Autoimmune Arthritis via T Helper 17 CellsImmunity, 2010
- Preclinical Rheumatoid Arthritis: Identification, Evaluation, and Future Directions for InvestigationRheumatic Disease Clinics of North America, 2010
- Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependentJournal of Experimental Medicine, 2010
- Cystic fibrosisThe Lancet, 2009
- The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17–producing effector T helper cells in vivoNature Immunology, 2009
- Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature, 2003